IL6 and breast carcinoma: Highly enriched of glycoprotein 130 (gp130) from breast cancer (BC)-derived exosomes triggers the secretion of interleukin-6 (IL-6) and activate the IL-6/STAT3 pathway (Ham et al., 2018).